CMND insider trading

NasdaqCM Healthcare

Clearmind Medicine Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
5
Last 90 days
5
Buys / sells
20% / 80%
Market cap
$3.02M

About Clearmind Medicine Inc.

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Company website: www.clearmindmedicine.com

CMND insider activity at a glance

FilingIQ has scored 5 insider transactions for CMND since Jun 10, 2026. The most recent filing in our index is dated Jun 16, 2026.

Across the full history, 1 open-market purchases and 4 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CMND insider trades is 50.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for CMND?
FilingIQ tracks 5 Form 4 insider transactions for CMND (Clearmind Medicine Inc.), covering filings from Jun 10, 2026 onwards. 5 of those were filed in the last 90 days.
Are CMND insiders net buyers or net sellers?
Across the full Form 4 history for CMND, 1 transactions (20%) were open-market purchases and 4 (80%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CMND insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CMND in?
Clearmind Medicine Inc. (CMND) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.02M.

Methodology & sources

Every CMND insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.